Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Böhm(Saarland University), Benjamin Blossom, Tolga Agdirlioglu(Sana Klinikum), Barry Bertolet, Masahiko Asami, E. Andrikou, Kazuomi Kario(Jichi Medical University), David P. Lee, Suhail Allaqaband, Kyle Bass, Stuart Pocock(University of London), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Sebastian Ewen(Saarland University), Felix Mahfoud(Saarland University), Vanessa DeBruin(Medtronic (United States)), Ahran Arnold, Jason Bloom, Faisal Sharif(Ollscoil na Gaillimhe – University of Galway), Michael A. Weber(SUNY Downstate Health Sciences University), David Reyes‐Leiva(Centennial Medical Center), Axel Schmid(Universitätsklinikum Erlangen), Raymond R. Townsend(University of Pennsylvania), William Bachinsky, Roland E. Schmieder, Debbie L. Cohen(University of Pennsylvania), Denise Reedus, Cara East(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Christian Binner, Martin Fahy(Medtronic (United States)), Konstantinos Tsioufis(Hippocration General Hospital), David E. Kandzari(Piedmont Atlanta Hospital), Janice P. Lea, Herbert D. Aronow, Jiro Aoki, Yvonne Bewarder, Karl Bihlmaier, Richard D’Souza(Royal Devon and Exeter Hospital), Chandan Devireddy, Sandeep Brar(Medtronic (United States)), John Barton, Andrew S.P. Sharp, Robert Wilensky, Chris Bell, Brian Jefferson(Centennial Medical Center), Adrian Ma(Stanford Health Care), Bryan Batson, Joachim Weil, Ertan Akarca, Sidney A. Cohen(University of Pennsylvania)
Cited by 586
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k